MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan

    A. Il'Yazova, C. Shambetova, E. Zhunusova (Bishkek, Kyrgyzstan)

  • Comorbid neuropathological features in multiple system atrophy

    H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

  • Comorbidities in Huntington’s disease: An Enroll-HD analysis

    J. Mills, J. Long, J. Vaidya, C. Sampaio, S. Sathe (Iowa City, USA)

  • Comparing duodenal levodopa infusion based on length of treatment in advanced Parkinson’s.

    J. Alonso Maroto, E. Casas Peña, I. Muro García, M. Domínguez Gallego, E. Valiente Gordillo, L. López Manzanares, JA. Vivancos Mora (Madrid, Spain)

  • Comparison between clinical and kinematic assessment of bradykinesia

    G. Paparella, A. de Biase, L. Angelini, A. Cannavacciuolo, D. Colella, A. Guerra, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

  • COMPARISON OF CERVICAL, OCULAR AND MASSETER VESTIBULAR EVOKED MYOGENIC POTENTIALS IN PARKINSON PATIENTS ACCORDING TO CLINICAL SUBGROUPS

    G. Sahbaz, R. Inan, B. Barut (Istanbul, Turkey)

  • COMPARISON OF COMPLICATIONS OF POST-COVID-19 IN PATIENTS WITH PARKINSONISM SYNDROME OF DIFFERENT GENESIS

    O. Tondiy (Kharkiv, Ukraine)

  • Comparison of different risk scores for Parkinson’s disease in a population-based 10-year study

    K. Marini, K. Seppi, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian-Tehrani, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

  • Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

    DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

  • Comparison of efficacy and safety of adjunct treatments to levodopa in patients with Parkinson’s disease and wearing-off: A network meta-analysis of randomized, double-blind trials

    Y. Kogo, W. Sako, M. Koebisu, H. Yamakage, T. Ishida, N. Hattori (Tokyo, Japan)

  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley